Cosmetic Modernization Amendments of 2015

H. R. 104, To protect cyber privacy, and for other purposes. HR 1309, Microbead-Free Waters Act of 2015 HR 1692, Personal Data Notification and Protection Act of 2015 HR 1758, Data Security and Breach Notification Act of 2015 HR 2193, Data Security Act of 2015 HR 4075, Cosmetic Modernization Amendments of 2015 HR 5205, Cleaning Product Right to Know Act of 2016 HR 5230, Anti-Pyramid Promotional Scheme Act of 2016 HR 5413, To amend the Consumer Financial Protection Act of 2010 to provide additional requirements for the consumer complaint website of the Bureau of Consumer Financial Protection, and for other purposes. HR 5491, To require the Director of the Bureau of Consumer Financial Protection to verify the accuracy of consumer complaint information before making such information available to the public. S. 952, Data Security Act of 2015 S. 1005, Personal Care Products Safety Act S. 1015, Great Lakes Restoration Initiative Act of 2015 S. 1018, Data Breach Notification and Punishing Cyber Criminals Act of 2015 S. 1149, Consumer Privacy Protection Act of 2015 S. 1415, Microbead-Free Waters Act of 2015

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 2777, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions. - HR 1192, "National Clinical Care Commission Act", regarding all provisions.

Client expense: $1,460,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

S.1014 - Personal Care Products Safety Act, all sections; and H.R.4075 - Cosmetic Modernization Amendments of 2015, all sections; and H.R. ______ - Draft legislation "To Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics."

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Consumer protection and product safety standards and regulations in cosmetics industry. Personal Care Products Act, S. 1014. Cosmetic Modernization Act - H.R. 4075

Client expense: Not reported · Firm income: $20,000

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Cosmetic Modernization Amendments of 2015 ( H.R. 4075).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

FDA regulation of cosmetics, including Good Manufacturing Practices, import safety, fragrance ingredients, national uniformity and FDA resources; H.R. 4075, Cosmetic Modernization Amendments of 2015 S. 1014, Personal Care Products Safety Act

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

S. 1014, Personal Care Product Act; cosmetic legislation H.R.34, 21st Century Cures Act (P.L.114-255) H.R. 4075, The Cosmetic Modernization Act Pallone/Lance Cosmetic Safety discussion draft

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol (including he Kigali amendment) and United Nations supporting language and the Paris Agreement. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations and EPA corrosivity regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015; S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $150,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office

Toxic Substances Control Act (TSCA) reauthorization legislation. S. 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act. H.R. 2576 - TSCA Modernization Act of 2015. Issues related to fluorochemicals, fluoropolymers, hydrofluorocarbons and/or Montreal Protocol and/or the Paris Agreement. EPA chemical regulations, including Significant New Use Rules and the Significant New Alternatives Policy program and EPA corrosivity regulations. Monitor: S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments. OSHA hazard communications issues.

Client expense: $150,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office

Human Trafficking Legislation: Justice for Victims of Trafficking Act (S. 178/HR 181) Stop Exploitation Through Trafficking Act (S. 166/HR 159) Bringing Missing Children Home Act of 2015 (S. 381) Combatting Human Trafficking Act of 2015 (S. 529) International Megan's Law to Prevent Demand for Child Sex Trafficking(H.R. 515) International Megans Law to Prevent Child Exploitation Through Advanced Notification of Traveling Sex Offenders (S. 1867) SAVE Act (S. 572) Runaway and Homeless Youth and Trafficking Prevention Act (S. 262) Trafficking Survivors Relief Act of 2016 (S. 3441) Adam Walsh Reauthorization Act of 2016 (S. 2613/H.R. 6133) Amy and Vicky Child Pornography Victim Restitution Improvement Act of 2015 (S. 295) Avonte's Law (S.163) Kevin and Avonte's Law of 2016 (S. 2614/H.R. 4919) Child Protections Improvement Act (H.R. 4075/S. 2332) Fairness for Crime Victims Act (S. 1495) Extending Justice for Sex Crime Victims Act of 2016 (S. 2895) Juvenile Justice and Delinquency Prevention Reauthorization Act of 2015 (S.1169) Protecting Students from Sexual and Violent Predators Act (S. 474) Protecting Our Servicemembers' Children from Sexual and Violent Predators Act (S. 2625) Section 578 of the National Defense Authorization Act (S. 2943) Helping Schools Protect Our Children Act of 2015 (S. 1369) Every Student Succeeds Act (S. 1177) Recovering Missing Children Act (H.R. 3209/S. 3016) International Child Abduction and Implementation of the Goldman Act to Return Abducted Children. Appropriations from Department of Justice (H.R. 5393/S. 2837) and Department of Homeland Security (H.R. 5634/S. 3001) for programs at the National Center for Missing and Exploited Children Implementation and funding for the Adam Walsh Act of 2006 Implementation of the Preventing Sex Trafficking and Strengthening Families Act of 2014 Kelsey Smith Act (H.R. 4881/S. 2770) Email Privacy Act (H.R. 699) Electronic Communications Privacy Act (S. 356) Encryption General Issues involving Efforts to Combat Child Pornography

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office for Victims of Crime, Office of Juvenile Justice & Delinquency Prevention, SENATE, U.S. Marshals Service

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $779,741 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

Client expense: $1,150,000 · Firm income: Not reported

Government targets: Consumer Financial Protection Bureau (CFPB), Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE

H.R.34, 21st Century Cures Act (P.L.114-255). Innovation for Healthier Americans. Cosmetic legislation including S.1014, Personal Care Products Safety Act, H.R.4075, Cosmetic Modernization Amendments of 2015 and the Pallone/Lance Cosmetic Safety Discussion Draft.

Client expense: $220,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)

S. 1014, The Personal Care Product and Safety Act, and its affects on the Handcrafted Soap and Cosmetic Industry and Small Businesses. HR. 4075, a bill that seeks to update and modernize the cosmetic industry reporting requirements to the FDA and its affects on the Handcrafted Soap and Cosmetic Industry

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA regulation of cosmetics, including Good Manufacturing Practices; import safety; fragrance ingredients; national uniformity and FDA resources; international trade and harmonization. S. 1014, The Personal Care Products Safety Act. H.R. 4075, Cosmetic Modernization Amendments of 2015.

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

S. 1014, The Personal Care Product and Safety Act, and its affects on the Handcrafted Soap and Cosmetic Industry and Small Businesses. HR. 4075, a bill that seeks to update and modernize the cosmetic industry reporting requirements to the FDA and its affects on the Handcrafted Soap and Cosmetic Industry

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $721,244 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Cosmetic Modernization Amendments of 2015 ( H.R. 4075).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

FDA authority over cosmetics companies, S 1014 (Feinstein-Collins)-Personal Care Products Safety Act; HR 4075 (Sessions)- Cosmetic Modernization Amendments of 2015

Client expense: Not reported · Firm income: $100,000

Government targets: SENATE

Consumer protection and product safety standards and regulations in cosmetics industry. Personal Care Products Act, S. 1014. Cosmetic Modernization Act - H.R. 4075

Client expense: Not reported · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

Client expense: $1,750,000 · Firm income: Not reported

Government targets: Education, Dept of, Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 277, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions.

Client expense: $890,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

FDA regulation of cosmetics, including Good Manufacturing Practices; import safety; fragrance ingredients; national uniformity and FDA resources; international trade and harmonization. S. 1014, The Personal Care Products Safety Act. H.R. 4075, Cosmetic Modernization Amendments of 2015.

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA regulation of cosmetics, including Good Manufacturing Practices, import safety, fragrance ingredients, national uniformity and FDA resources; H.R. 4075, Cosmetic Modernization Amendments of 2015 S. 1014, Personal Care Products Safety Act

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1014 - Personal Care Products Safety Act, all sections; and H.R.4075 - Cosmetic Modernization Amendments of 2015, all sections; and H.R. ______ - Draft legislation "To Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics."

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Essential oils and wellness products related issues and initiatives. Monitor the following: H.R.4469/S.2499, Health Savings Act of 2016, Eligibility of dietary supplements in Flexibile Spending Accounts (FSA) and Health Savings Accounts (HSA). H.R.4075, Cosmetic Modernization Amendments of 2015 S.1014, Personal Care Products Safety Act GMO labeling legislation Cosmetics legislation

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol and United Nations supporting language. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations and EPA corrosivity regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015; S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $140,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

Toxic Substances Control Act (TSCA) reauthorization legislation. S. 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act. H.R. 2576 - TSCA Modernization Act of 2015. Issues related to fluorochemicals, fluoropolymers, hydrofluorocarbons and/or Montreal Protocol. EPA chemical regulations, including Significant New Use Rules and the Significant New Alternatives Policy program and EPA corrosivity regulations. Monitor: S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments. OSHA hazard communications issues.

Client expense: $140,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

S. 1014, Personal Care Product Act; cosmetic legislation H.R. 6, 21st Century Cures Innovation for Healthier Americans H.R. 4075, The Cosmetic Modernization Act Pallone/Lance Cosmetic Safety discussion draft

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Human Trafficking Legislation: Justice for Victims of Trafficking Act (S. 178/HR 181) Stop Exploitation Through Trafficking Act (S. 166/HR 159) Bringing Missing Children Home Act of 2015 (S. 381) Combatting Human Trafficking Act of 2015 (S. 529) International Megan's Law to Prevent Demand for Child Sex Trafficking(H.R. 515) International Megans Law to Prevent Child Exploitation Through Advanced Notification of Traveling Sex Offenders (S. 1867) SAVE Act (S. 572) Runaway and Homeless Youth and Trafficking Prevention Act (S. 262) Trafficking Survivors Relief Act of 2016 (S. 3441) Adam Walsh Reauthorization Act of 2016 (S. 2613/H.R. 6133) Amy and Vicky Child Pornography Victim Restitution Improvement Act of 2015 (S. 295) Avonte's Law (S.163) Kevin and Avonte's Law of 2016 (S. 2614/H.R. 4919) Child Protections Improvement Act (H.R. 4075/S. 2332) Fairness for Crime Victims Act (S. 1495) Extending Justice for Sex Crime Victims Act of 2016 (S. 2895) Juvenile Justice and Delinquency Prevention Reauthorization Act of 2015 (S.1169) Protecting Students from Sexual and Violent Predators Act (S. 474) Protecting Our Servicemembers' Children from Sexual and Violent Predators Act (S. 2625) Section 578 of the National Defense Authorization Act (S. 2943) Helping Schools Protect Our Children Act of 2015 (S. 1369) Every Student Succeeds Act (S. 1177) Recovering Missing Children Act (H.R. 3209/S. 3016) International Child Abduction and Implementation of the Goldman Act to Return Abducted Children. Appropriations from Department of Justice (H.R. 5393/S. 2837) and Department of Homeland Security (H.R. 5634/S. 3001) for programs at the National Center for Missing and Exploited Children Implementation and funding for the Adam Walsh Act of 2006 Implementation of the Preventing Sex Trafficking and Strengthening Families Act of 2014 Kelsey Smith Act (H.R. 4881/S. 2770) Email Privacy Act (H.R. 699) Electronic Communications Privacy Act (S. 356) General Issues involving Encryption

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office for Victims of Crime, Office of Juvenile Justice & Delinquency Prevention, SENATE, U.S. Marshals Service

H.R.6, 21st Century Cures Act. Innovation for Healthier Americans. Cosmetic legislation including S.1014, Personal Care Products Safety Act, H.R.4075, Cosmetic Modernization Amendments of 2015 and the Pallone/Lance Cosmetic Safety Discussion Draft.

Client expense: $220,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

HR 104, To protect cyber privacy, and for other purposes. HR 1309, Microbead-Free Waters Act of 2015 HR 1692, Personal Data Notification and Protection Act of 2015 HR 1758, Data Security and Breach Notification Act of 2015 HR 2193, Data Security Act of 2015 HR 4075, Cosmetic Modernization Amendments of 2015 H.R.5205, Cleaning Product Right to Know Act of 2016 H.R.5230, Anti-Pyramid Promotional Scheme Act of 2016 H. R. 5413, To amend the Consumer Financial Protection Act of 2010 to provide additional requirements for the consumer complaint website of the Bureau of Consumer Financial Protection, and for other purposes. H.R.5491, To require the Director of the Bureau of Consumer Financial Protection to verify the accuracy of consumer complaint information before making such information available to the public. S. 952, Data Security Act of 2015 S. 1005, Personal Care Products Safety Act S. 1015, Great Lakes Restoration Initiative Act of 2015 S. 1018, Data Breach Notification and Punishing Cyber Criminals Act of 2015 S. 1149, Consumer Privacy Protection Act of 2015 S. 1415, Microbead-Free Waters Act of 2015

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA regulation of cosmetics, including Good Manufacturing Practices, import safety, fragrance ingredients, national uniformity and FDA resources; H.R. 4075, Cosmetic Modernization Amendments of 2015 S. 1014, Personal Care Products Safety Act

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 1321 / S.1424, Microbead Free Waters Act of 2015 - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $783,084 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

FDA regulation of cosmetics, including Good Manufacturing Practices; import safety; fragrance ingredients; national uniformity and FDA resources; international trade and harmonization. S. 1014, The Personal Care Products Safety Act. H.R. 4075, Cosmetic Modernization Amendments of 2015.

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Supporting and assisting in the drafting and introduction the Traveling Exotic Animal and Public Safety Protection Act or TEAPSPA) in the House and Senate; all provisions related to and supporting ending the suffering of animals in US traveling performances, rides, or exhibits, and to address the inherent health and safety risks such events pose to workers and the public. Support the following bills to the extent they protect animals from harm and end animal suffering, and as yet unknown issues related to ADI's overarching goal for longstanding change to end animal suffering: HR2576 (with provisions mandating to limit animal testing and seek alternatives); HR3546 (Big Cat and Public Safety Act), HR2858 (Humane Cosmetics Act); HR2494 (Global Anti-Poaching Act) as amended in the Senate (wholly substituted with S2385; opposed to prior HR2494 House amendment exempting trophy hunting); HR2920 (Captive Primate Safety Act); S2385 (END Wildlife Trafficking Act); HR2697 (Rare Cats and Canids Act); HR2293/S1831 PACT (re the prosecution of animal cruelty); HR746/S388 AWARE (re testing at federal agricultural research facilities); HR3294/S1898 (Sanctuary Regulatory Fairness Act of 2015); HR3526/S1918 (CECIL Animal Trophies Act); HR3448 (Cecil the Lion Endangered and Threatened Species Act of 2015); HR1942/S1214 (Safeguard American Food Exports Act); HR4019 (ORCA Act); HR1258 (Pet and Women Safety Act); HR3294/S1898 (Sanctuary Regulatory Fairness Act), Volunteer Protection Act & Volunteer Organization Act of 2015; and in opposition to (for the same reasons) S405 (Sportsmen's Act), S659 (The Bipartisan Sportsmen's Act of 2015), and S782 (The Grand Canyon Bison Management Act); and urging a provision against animal testing in HR4075 (The Cosmetic Modernization Act). Also prepared comments for submission to USFWS re manatee down listing; proposed grizzly down listing; re proposed ivory import ban, African elephant uplisting; re listing Russian belugas as depleted; and re generic tiger loophole; re opposition to HCP development threatening Florida panthers & 6 other ESA listed species; re USFWS permitting of exotic /wild animals; and to USDA re proposed captive marine mammal rule making; re call for comments re Petition to prohibit public contact with bears, big cats, and nonhuman primates; and their rescinding mandatory TB testing in captive elephants. Research re USFWS Wildlife Trafficking Advisory Council; re US House Agriculture Committee meeting re farm animal regulation.

Client expense: $5,222 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Fish & Wildlife Service (USFWS)

Cosmetic Modernization Amendments of 2015 ( H.R. 4075).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

Toxic Substances Control Act (TSCA) reauthorization legislation. S. 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act. H.R. 2576 - TSCA Modernization Act of 2015. Issues related to fluorochemicals, fluoropolymers, hydrofluorocarbons and/or Montreal Protocol. EPA chemical regulations, including Significant New Use Rules and the Significant New Alternatives Policy program and EPA corrosivity regulations. Monitor: S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $100,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations and EPA corrosivity regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015; S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $100,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

Consumer protection and product safety standards and regulations in cosmetics industry. Personal Care Products Act, S. 1014. Cosmetic Modernization Act - H.R. 4075

Client expense: Not reported · Firm income: $10,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1014, The Personal Care Product and Safety Act, and its affects on the Handcrafted Soap and Cosmetic Industry and Small Businesses. HR. 4075, a bill that seeks to update and modernize the cosmetic industry reporting requirements to the FDA and its affects on the Handcrafted Soap and Cosmetic Industry

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE